關鍵數據
3.780今開
4.010最高
152.47K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.32%換手率
3.730昨收
3.710最低
421.97K成交額
虧損本益比靜
3.52市淨率
0.00%股息率 TTM
-35.73%ROA
4.75052週最高
0.58量比
-33.42M淨利潤
47.39M總股本
-0.5145每股盈餘TTM
0.59Beta
-63.26%ROE
1.30052週最低
8.04%振幅
--毛利率
247.69M總市值
-0.82回報/風險
6.20%風險率
Adagene Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Adagene Inc簡介
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.
公司代碼ADAG
公司Adagene Inc
CEOLuo (Peter)
網址https://www.adagene.com/
公司股東
常見問題
Adagene Inc(ADAG)的當前股價是多少?
Adagene Inc(ADAG)的當前股價是 3.75。
Adagene Inc股票的52週最高點是多少?
Adagene Inc股票的52週最高點是4.75。
Adagene Inc股票的52週最低點是多少?
Adagene Inc股票的52週最低點是1.30。
現在Adagene Inc(ADAG)的股票是買入、持有還是賣出?
根據分析師評級,Adagene Inc(ADAG)的總體評級為買入,目標價格為10.74。
Adagene Inc(ADAG)股票的每股收益(EPS TTM)是多少
Adagene Inc(ADAG)股票的每股收益(EPS TTM)是-0.37。